Suppr超能文献

罕见病登记处的质量评估——对疾病登记处基本特征的评估。

The Quality Evaluation of Rare Disease Registries-An Assessment of the Essential Features of a Disease Registry.

机构信息

Developmental Endocrinology Research Group, Royal Hospital for Children, University of Glasgow, Glasgow G51 4TF, UK.

Office for Rare Conditions, University of Glasgow, Glasgow G51 4TF, UK.

出版信息

Int J Environ Res Public Health. 2021 Nov 15;18(22):11968. doi: 10.3390/ijerph182211968.

Abstract

Rare disease (RD) registries aim to promote data collection and sharing, and facilitate multidisciplinary collaboration with the overall aim of improving patient care. Recommendations relating to the minimum standards necessary to develop and maintain high quality registries are essential to ensure high quality data and sustainability of registries. The aim of this international study was to survey RD registry leaders to ascertain the level of consensus amongst the RD community regarding the quality criteria that should be considered essential features of a disease registry. Of 35 respondents representing 40 RD registries, over 95% indicated that essential quality criteria should include establishment of a good governance system (ethics approval, registry management team, standard operating protocol and long-term sustainability plan), data quality (personnel responsible for data entry and procedures for checking data quality) and construction of an IT infrastructure complying with Findable, Accessible, Interoperable and Reusable (FAIR) principles to maintain registries of high quality, with procedures for authorized user access, erasing personal data, data breach procedures and a web interface. Of the 22 registries that performed a self-assessment, over 80% stated that their registry had a leader, project management group, steering committee, active funding stream, website, and user access policies. This survey has acceptability amongst the RD community for the self-quality evaluation of RD registries with high levels of consensus for the proposed quality criteria.

摘要

罕见病(RD)登记处旨在促进数据收集和共享,并促进多学科合作,总体目标是改善患者护理。制定和维护高质量登记处所需的最低标准的建议对于确保高质量数据和登记处的可持续性至关重要。本国际研究旨在调查 RD 登记处负责人,以确定 RD 社区在应考虑作为疾病登记处基本特征的质量标准方面的共识程度。在代表 40 个 RD 登记处的 35 名受访者中,超过 95%的人表示,基本质量标准应包括建立良好的治理系统(伦理批准、登记处管理团队、标准操作协议和长期可持续性计划)、数据质量(负责数据录入的人员和检查数据质量的程序)和构建符合可发现性、可访问性、互操作性和可重用性(FAIR)原则的 IT 基础设施,以维护高质量的登记处,并有授权用户访问、删除个人数据、数据泄露程序和网络界面的程序。在进行自我评估的 22 个登记处中,超过 80%的登记处表示其有负责人、项目管理小组、指导委员会、积极的资金流、网站和用户访问政策。这项调查在 RD 社区中是可以接受的,因为它对 RD 登记处进行了自我质量评估,并且对拟议的质量标准达成了高度共识。

相似文献

1
The Quality Evaluation of Rare Disease Registries-An Assessment of the Essential Features of a Disease Registry.
Int J Environ Res Public Health. 2021 Nov 15;18(22):11968. doi: 10.3390/ijerph182211968.
2
3
Recommendations for Improving the Quality of Rare Disease Registries.
Int J Environ Res Public Health. 2018 Aug 3;15(8):1644. doi: 10.3390/ijerph15081644.
5
Rare disease registries: a call to action.
Intern Med J. 2017 Sep;47(9):1075-1079. doi: 10.1111/imj.13528.
7
Critical Care Network in the State of Qatar.
Qatar Med J. 2019 Nov 7;2019(2):2. doi: 10.5339/qmj.2019.qccc.2. eCollection 2019.
8
The RD-Connect Registry & Biobank Finder: a tool for sharing aggregated data and metadata among rare disease researchers.
Eur J Hum Genet. 2018 May;26(5):631-643. doi: 10.1038/s41431-017-0085-z. Epub 2018 Feb 2.
9
Scoping review of the recommendations and guidance for improving the quality of rare disease registries.
Orphanet J Rare Dis. 2024 May 6;19(1):187. doi: 10.1186/s13023-024-03193-y.
10
A model for the European platform for rare disease registries.
Public Health Genomics. 2013;16(6):299-304. doi: 10.1159/000355935. Epub 2014 Feb 3.

引用本文的文献

1
The role of public health in rare diseases: hemophilia as an example.
Front Public Health. 2025 Mar 20;13:1450625. doi: 10.3389/fpubh.2025.1450625. eCollection 2025.
2
Scoping review of the recommendations and guidance for improving the quality of rare disease registries.
Orphanet J Rare Dis. 2024 May 6;19(1):187. doi: 10.1186/s13023-024-03193-y.
3
Informing a national rare disease registry strategy in Australia: a mixed methods study.
BMC Health Serv Res. 2023 Oct 31;23(1):1187. doi: 10.1186/s12913-023-10049-x.
5
GLUT1-DS Italian registry: past, present, and future: a useful tool for rare disorders.
Orphanet J Rare Dis. 2023 Mar 21;18(1):63. doi: 10.1186/s13023-023-02628-2.
6
Hereditary Endocrine Tumor Registries.
J Endocr Soc. 2022 Dec 23;7(3):bvac194. doi: 10.1210/jendso/bvac194. eCollection 2023 Jan 6.
7
Global Registries in Congenital Hyperinsulinism.
Front Endocrinol (Lausanne). 2022 Jun 2;13:876903. doi: 10.3389/fendo.2022.876903. eCollection 2022.
8
Rare Disease Registries Are Key to Evidence-Based Personalized Medicine: Highlighting the European Experience.
Front Endocrinol (Lausanne). 2022 Mar 4;13:832063. doi: 10.3389/fendo.2022.832063. eCollection 2022.

本文引用的文献

1
Progress, challenges and global approaches to rare diseases.
Acta Paediatr. 2021 Oct;110(10):2711-2716. doi: 10.1111/apa.15974. Epub 2021 Jun 19.
3
Lessons learned from hemolytic uremic syndrome registries: recommendations for implementation.
Orphanet J Rare Dis. 2021 May 25;16(1):240. doi: 10.1186/s13023-021-01871-9.
5
6
The current landscape of European registries for rare endocrine conditions.
Eur J Endocrinol. 2019 Jan 1;180(1):89-98. doi: 10.1530/EJE-18-0861.
7
Recommendations for Improving the Quality of Rare Disease Registries.
Int J Environ Res Public Health. 2018 Aug 3;15(8):1644. doi: 10.3390/ijerph15081644.
9
Data Quality in Rare Diseases Registries.
Adv Exp Med Biol. 2017;1031:149-164. doi: 10.1007/978-3-319-67144-4_8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验